A Harvard led study has identified gut derived metabolites that travel to the liver and influence insulin sensitivity, fat metabolism, and energy use. These molecules shift with diet and genetics, and some improved insulin signalling in lab tests. The findings suggest new therapeutic strategies for preventing or managing obesity and type 2 diabetes.